In our DMD organoid analysis, we observed both elevated FAP activation (increased levels of proinflammatory markers: IGF1, COL5A3, and MMP2) and concurrent myogenic progenitor dysregulation (reduced levels of resting progenitors: 34.49% to 7.65–19.65%). The gene discussed is COL5A3; the disease is Duchenne muscular dystrophy.